Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cioffi

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Internal and Emergency Medicine|March 30, 2020
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunctionGiovanni Cioffi, Ombretta Viapiana, Luigi Tarantini, et al.
Journal of Cardiac Failure|December 16, 2004
Dilated versus nondilated cardiomyopathy in the elderly population treated with guideline-based medical therapy for systolic chronic heart failureGiovanni Cioffi, Luigi Tarantini, Stefania De Feo, et al.
Diabetes Research and Clinical Practice|July 27, 2013
The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE studyGiacomo Faden, Giorgio Faganello, Stefania De Feo, et al.
Cardiovascular Drugs and Therapy|August 17, 2019
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study PopulationCarlo Bruno Giorda, Giovanni Cioffi, Donata Lucci, et al.
The American Journal of Cardiology|February 26, 2014
Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitusGiovanni Cioffi, Andrea Rossi, Giovanni Targher, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 21, 2005
Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational studyCristina Opasich, Stefania De Feo, Giovanni Cioffi, et al.
International Journal of Cardiology|August 10, 2013
Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetesGiovanni Cioffi, Andrea Rossi, Giacomo Zoppini, et al.
International Journal of Cardiology|November 16, 2013
Impact of aortic or mitral valve sclerosis and calcification on cardiovascular events and mortality: a meta-analysisDanitza Pradelli, Giacomo Faden, Gianfrancesco Mureddu, et al.
The American Journal of Cardiology|June 22, 2025
Insights into the Benefits of Reverse Remodeling from an Echocardiographic Pressure/Volume Loop Model in Patients With Heart Failure Treated With Sacubitril/ValsartanFrank L Dini, Giovanni Cioffi, Erberto Carluccio, et al.
European Journal of Preventive Cardiology|March 23, 2021
Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trialGiovanni Cioffi, Carlo Bruno Giorda, Donata Lucci, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Internal and Emergency Medicine|March 30, 2020
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunctionGiovanni Cioffi, Ombretta Viapiana, Luigi Tarantini, et al.
Journal of Cardiac Failure|December 16, 2004
Dilated versus nondilated cardiomyopathy in the elderly population treated with guideline-based medical therapy for systolic chronic heart failureGiovanni Cioffi, Luigi Tarantini, Stefania De Feo, et al.
Diabetes Research and Clinical Practice|July 27, 2013
The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE studyGiacomo Faden, Giorgio Faganello, Stefania De Feo, et al.
Cardiovascular Drugs and Therapy|August 17, 2019
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study PopulationCarlo Bruno Giorda, Giovanni Cioffi, Donata Lucci, et al.
The American Journal of Cardiology|February 26, 2014
Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitusGiovanni Cioffi, Andrea Rossi, Giovanni Targher, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 21, 2005
Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational studyCristina Opasich, Stefania De Feo, Giovanni Cioffi, et al.
International Journal of Cardiology|August 10, 2013
Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetesGiovanni Cioffi, Andrea Rossi, Giacomo Zoppini, et al.
International Journal of Cardiology|November 16, 2013
Impact of aortic or mitral valve sclerosis and calcification on cardiovascular events and mortality: a meta-analysisDanitza Pradelli, Giacomo Faden, Gianfrancesco Mureddu, et al.
The American Journal of Cardiology|June 22, 2025
Insights into the Benefits of Reverse Remodeling from an Echocardiographic Pressure/Volume Loop Model in Patients With Heart Failure Treated With Sacubitril/ValsartanFrank L Dini, Giovanni Cioffi, Erberto Carluccio, et al.
European Journal of Preventive Cardiology|March 23, 2021
Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trialGiovanni Cioffi, Carlo Bruno Giorda, Donata Lucci, et al.
Pageof 15